Back

Should we avoid transvenous defibrillator therapy?

17 April 2023 (18:00 - 18:15)
Organised by:
Congress Presentation Part of: Defibrillator therapy without a lead in the heart Implantable Cardioverter-Defibrillator (ICD) EHRA Premium Access EHRA 2023

About the speaker

Photo
Professor Jeff Healey

Population Health Research Institute, Hamilton (Canada)

3 More presentations in this session

Presentation thumbnail
Has the S-ICD become standard of care?
Professor P. Lambiase (London, GB)
Slides Video
Presentation thumbnail
Modular therapy with S-ICD and leadless pacing
Assistant Professor F. Tjong (Amsterdam, NL)
Slides Video
Presentation thumbnail
Does the substernal ICD meet our needs?
Doctor N. Clementy (Montpellier, FR)
Slides Video

Access the full session

Session thumbnail
Defibrillator therapy without a lead in the heart
Video

The Event

Event poster

EHRA 2023

17 April 2023 18:00 CET
You may be interested in
thumbnail
Congress Presentation
Implantable cardioverter-defibrillator in primary prevention should be leadless
thumbnail
Congress Presentation
Is the S-ICD safer than the transvenous ICD?
thumbnail
Congress Presentation
Debating the future of implantable cardioverter-defibrillator therapy - subcutaneous implantable cardioverter-defibrillator with antitachycardia pacing: the safer leadless system, now with complete therapy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources